Journal Article
. 2008 Nov; 181(10):6829-36.
doi: 10.4049/jimmunol.181.10.6829.

Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV

Marielle A Otten 1 Gerben J van der Bij  Sjef J Verbeek  Falk Nimmerjahn  Jeffrey V Ravetch  Robert H J Beelen  Jan G J van de Winkel  Marjolein van Egmond  
  • PMID: 18981101
  •     30 citations


Many patients with colorectal cancer will develop liver metastases, even after successful surgical removal of the primary tumor at a time at which no visible metastases are present. We previously demonstrated that surgery--although mandatory--paradoxically enhances the risk of developing liver metastases. Because Ab therapy has been acknowledged as a successful strategy to treat malignancies, we studied the potential of postoperative adjuvant Ab therapy to prevent outgrowth of liver metastases. Treatment with murine anti-gp75 (TA99) mAb completely prevented outgrowth of B16F10 liver metastases in over 90% of mice. Therapeutic efficacy was maintained in either C1q- or complement receptor 3-deficient mice but was completely abrogated in FcR gamma-chain knockout mice. This indicates that the classical complement pathway was not essential, but interaction with activatory Fc gammaR was necessary for successful therapy. TA99-treatment was still effective in Fc gammaRI(-/-), Fc gammaRIII(-/-), Fc gammaRI/III(-/-), and Fc gammaRI/II/III(-/-) mice, suggesting an important role for Fc gammaRIV. However, wild-type mice that were treated with TA99 Abs and an Fc gammaRIV blocking Ab (mAb 9E9) were protected against development of liver metastases as well. Only when both Fc gammaRI and Fc gammaRIV functions were simultaneously inhibited, TA99-mediated curative Ab treatment was abrogated, indicating functional redundancy between both IgG receptors in the liver. Furthermore, depletion of liver macrophages (Kupffer cells) reduced the efficacy of Ab therapy, supporting that Kupffer cells are involved as effector cells. Importantly, since Ab treatment almost completely prevented development of liver metastases, postoperative adjuvant Ab therapy may help to improve patient prognosis.

Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.
Joel F G Cohen-Solal, Lydie Cassard, +3 authors, Catherine Sautès-Fridman.
Dermatol Res Pract, 2010 Jul 31; 2010. PMID: 20672001    Free PMC article.
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.
Francesca Avogadri, Taha Merghoub, +6 authors, Jedd D Wolchok.
PLoS One, 2010 Sep 17; 5(9). PMID: 20844763    Free PMC article.
FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.
Falk Nimmerjahn, Anja Lux, +5 authors, Jeffrey V Ravetch.
Proc Natl Acad Sci U S A, 2010 Oct 27; 107(45). PMID: 20974962    Free PMC article.
Translating basic mechanisms of IgG effector activity into next generation cancer therapies.
Falk Nimmerjahn, Jeffrey V Ravetch.
Cancer Immun, 2012 Aug 17; 12. PMID: 22896758    Free PMC article.
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab, Falk Nimmerjahn.
Nat Rev Immunol, 2013 Feb 16; 13(3). PMID: 23411799
Highly Cited. Review.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy.
Nuray Gül, Liane Babes, +7 authors, Marjolein van Egmond.
J Clin Invest, 2014 Jan 17; 124(2). PMID: 24430180    Free PMC article.
Highly Cited.
Macrophages in the liver prevent metastasis by efficiently eliminating circulating tumor cells after monoclonal antibody immunotherapy.
Nuray Gül, Liane Babes, Paul Kubes, Marjolein van Egmond.
Oncoimmunology, 2014 Jul 23; 3. PMID: 25050211    Free PMC article.
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
Saskia Meyer, Jeanette H W Leusen, Peter Boross.
MAbs, 2014 Dec 18; 6(5). PMID: 25517299    Free PMC article.
Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.
Marina Moskalenko, Michael Pan, +11 authors, Yvonne Saenger.
Cancer Immunol Res, 2015 Jan 21; 3(3). PMID: 25600438    Free PMC article.
Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect.
David J DiLillo, Jeffrey V Ravetch.
Cell, 2015 May 16; 161(5). PMID: 25976835    Free PMC article.
Highly Cited.
Potent anti-tumor effects of EGFR-targeted hybrid peptide on mice bearing liver metastases.
Arong Gaowa, Tomohisa Horibe, +3 authors, Koji Kawakami.
Clin Exp Metastasis, 2015 Oct 16; 33(1). PMID: 26467564
The role of macrophages in bone metastasis.
Ifigenia Vasiliadou, Ingunn Holen.
J Bone Oncol, 2013 Dec 01; 2(4). PMID: 26909287    Free PMC article.
Translating Inhibitory Fc Receptor Biology into Novel Therapeutic Approaches.
Falk Nimmerjahn.
J Clin Immunol, 2016 Mar 10; 36 Suppl 1. PMID: 26957094
CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes.
Wei Hseun Yeap, Kok Loon Wong, +7 authors, Siew Cheng Wong.
Sci Rep, 2016 Sep 28; 6. PMID: 27670158    Free PMC article.
Highly Cited.
Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
Rens Braster, Simran Grewal, +4 authors, Marijn Bögels.
PLoS One, 2017 May 26; 12(5). PMID: 28542406    Free PMC article.
PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.
Laetitia They, Henri-Alexandre Michaud, +8 authors, Laurent Gros.
Oncoimmunology, 2017 Nov 11; 6(10). PMID: 29123966    Free PMC article.
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.
Anna H Turaj, Khiyam Hussain, +19 authors, Sean H Lim.
Cancer Cell, 2017 Dec 05; 32(6). PMID: 29198913    Free PMC article.
Artificial Anti-Tumor Opsonizing Proteins with Fibronectin Scaffolds Engineered for Specificity to Each of the Murine FcγR Types.
Tiffany F Chen, Kevin K Li, +5 authors, K Dane Wittrup.
J Mol Biol, 2018 Apr 29; 430(12). PMID: 29704491    Free PMC article.
FcγRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccines.
Hreinn Benonisson, Heng Sheng Sow, +9 authors, Sjef Verbeek.
Oncotarget, 2018 Jul 24; 9(50). PMID: 30034625    Free PMC article.
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies.
José Medina-Echeverz, Maria Hinterberger, +11 authors, Henning Lauterbach.
Nat Commun, 2019 Nov 07; 10(1). PMID: 31695037    Free PMC article.
Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy.
Xiaoming Zhong, Hangtian Zhang, +13 authors, Zunfu Ke.
Mol Cancer, 2020 Jan 26; 19(1). PMID: 31980023    Free PMC article.
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines.
Channakeshava Sokke Umeshappa, Santiswarup Singha, +7 authors, Pere Santamaria.
Nat Commun, 2019 May 16; 10(1). PMID: 31089130    Free PMC article.
Fc receptors as adaptive immunoreceptors.
Marc Daëron.
Curr Top Microbiol Immunol, 2014 Aug 15; 382. PMID: 25116099    Free PMC article.
Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance.
Jonathan J Pinney, Fátima Rivera-Escalera, +6 authors, Michael R Elliott.
Blood, 2020 Jun 20; 136(18). PMID: 32556153    Free PMC article.
Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice.
Rens Braster, Marijn Bögels, +8 authors, Gestur Vidarsson.
Cancers (Basel), 2021 Jun 03; 13(10). PMID: 34069226    Free PMC article.
Differential and sequential immunomodulatory role of neutrophils and Ly6Chi inflammatory monocytes during antiviral antibody therapy.
Jennifer Lambour, Mar Naranjo-Gomez, Myriam Boyer-Clavel, Mireia Pelegrin.
Emerg Microbes Infect, 2021 Apr 17; 10(1). PMID: 33858301    Free PMC article.
There Is Strength in Numbers: Quantitation of Fc Gamma Receptors on Murine Tissue-Resident Macrophages.
Christof Vorsatz, Niklas Friedrich, Falk Nimmerjahn, Markus Biburger.
Int J Mol Sci, 2021 Nov 28; 22(22). PMID: 34830050    Free PMC article.
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells.
Mandy Gruijs, Rens Braster, +8 authors, Marjolein van Egmond.
J Oncol, 2022 Jan 18; 2022. PMID: 35035479    Free PMC article.
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.
Lin Tian, Anhua Lei, +4 authors, Jin Zhang.
Kidney Dis (Basel), 2022 Mar 01; 8(1). PMID: 35224005    Free PMC article.